由于过去30年来癌症治疗, 日本的AML病例增加了三倍. Japanese AML rates triple due to cancer treatments over last three decades.

发表在"癌症"杂志上的一项研究发现, 日本的急性髓白血病与治疗相关的发病率正在增加, 在过去三十年中几乎翻了一番. A recent study published in the journal Cancer has found a rising incidence of therapy-related acute myeloid leukemia in Japan, with rates nearly tripling over the last three decades. 研究人员分析了30年来数据, 发现与癌症治疗相关的AML病例比例几乎翻了一倍, 从血液癌变为乳腺癌的主要原因. Analyzing over 30 years of data, researchers found that the proportion of AML cases linked to prior cancer treatment nearly doubled, shifting from blood cancers to breast cancer as the leading cause. 随着治疗的进步,癌症幸存者生存率增加了. The study highlights the need for better long-term monitoring of cancer survivors as treatment advances increase their survival rates.